Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
Upstream (Parents) |
---|
(<<) XPNPEP1 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) PRR5L → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) ID1 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) CASP5 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) OR1A2 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) CD6 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) HAVCR1 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
(<<) PLAC1 → LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ |
Downstream (Children) |
---|
LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ → PQLC2 (>>) |
LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ → OR1A2 (>>) |
LOC100126583///LOC652494///IGHM///IGHG3///IGHG2///IGHG1///IGHA1///IGH@ → TNNI3K (>>) |